Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Overview of attention for article published in Journal of Clinical Oncology, May 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
policy: 2 policy sources
twitter: 32 X users

patent: 19 patents
facebook: 4 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 534 Mendeley

So far, Altmetric has seen 6 news stories from 5 outlets.

Progress Emerging With Optimal Adjuvant Therapy in Young Women With Breast Cancer

OncLive, 13 Oct 2018

Mark Robson, MD Determining the optimal adjuvant therapy in young women with breast cancer remains challenging, but some…

ASCO's New Guideline for Endocrine Therapy in Breast Cancer

Medscape, 01 Jun 2016

The American Society of Clinical Oncology (ASCO) has issued a new guideline for the use of endocrine therapy in the treatment…

ASTRAZENECA’S FASLODEX MET PRIMARY ENDPOINT IN FIRST-LINE TREATMENT OF ADVANCED BREAST CANCER

PM 360, 27 May 2016

AstraZeneca today announced positive results from the Phase III FALCON trial comparing Faslodex 500mg (fulvestrant) to Arimidex…

AstraZeneca’s Faslodex met primary endpoint in first-line treatment of advanced breast cancer

My News Desk, 27 May 2016

AstraZeneca today announced positive results from the Phase III FALCON trial comparing Faslodex 500mg (fulvestrant) to Arimidex…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.